Collection
Molecular Imaging in Neurodegeneration
- Submission status
- Open
- Open for submission from
- 19 July 2023
- Submission deadline
- Ongoing
Editors
-
Fang Xie, PhD
Department of Nuclear Medicine & PET center, Huashan Hospital, Fudan University, China. His research interests include the development of radiotracers for cancer and brain disorders, neuroimaging and biomarkers of early signs of neurodegenerations He led translation of more than 10 radiotracers at Huahsan Hospital. He also led the establishment of a Chinese local AD cohort (C-PAS, Chinese preclinical Alzheimer’s Disease study) with more than 2000 amyloid PET scans and various other PET scans, including tau, SV2A, and mGluR5 PET.
-
Ruiqing Ni, PhD
Institute for Regenerative Medicine and Institute for Biomedical Engineering, University of Zurich and ETH Zurich, Switzerland. Her research focuses on the development of imaging biomarkers targeting amyloid-beta, tau and neuroinflammation for the early detection of Alzheimer’s disease and Parkinson’s disease and multiscale preclinical imaging techniques. She completed a PhD in Medical Science at Karolinska Institutet and postdoctoral training at the National Institute of Radiological Sciences (JSPS fellowship) and ETH Zurich.
Articles (21 in this collection)
-
-
Near-infrared II theranostic agents for the diagnosis and treatment of Alzheimer’s disease
Authors (first, second and last of 8)
- Can Zhou
- Fantian Zeng
- Jian Yang
- Content type: Review Article
- Published: 19 March 2024
-
Exploring the nigrostriatal and digestive interplays in Parkinson’s disease using dynamic total-body [11C]CFT PET/CT
Authors (first, second and last of 10)
- Mei Xin
- Yihan Wang
- Jianjun Liu
- Content type: Original Article
- Published: 23 February 2024
-
Collection on molecular imaging in neurodegeneration
Authors
- Fang Xie
- Ruiqing Ni
- Content type: Editorial
- Published: 22 July 2023
- Pages: 3166 - 3167
-
Prognostic value of imaging-based ATN profiles in a memory clinic cohort
Authors (first, second and last of 6)
- Débora E. Peretti
- Federica Ribaldi
- Valentina Garibotto
- Content type: Original Article
- Open Access
- Published: 26 June 2023
- Pages: 3313 - 3323
-
No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome
Authors (first, second and last of 6)
- Tassilo Schiebler
- Ivayla Apostolova
- Ralph Buchert
- Content type: Original Article
- Open Access
- Published: 17 June 2023
- Pages: 3302 - 3312
-
Occipital hypometabolism is a risk factor for conversion to Parkinson’s disease in isolated REM sleep behaviour disorder
Authors (first, second and last of 9)
- Giulia Carli
- Sanne K. Meles
- the REMPET Working Group
- Content type: Original Article
- Open Access
- Published: 13 June 2023
- Pages: 3290 - 3301
-
Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods
Authors (first, second and last of 14)
- Aleksandar Jovalekic
- Núria Roé-Vellvé
- Santiago Bullich
- Content type: Original Article
- Open Access
- Published: 10 June 2023
- Pages: 3276 - 3289
-
[18F]DPA-714: Effect of co-medications, age, sex, BMI and TSPO polymorphism on the human plasma input function
Authors (first, second and last of 14)
- MA Peyronneau
- B Kuhnast
- M. Bottlaender
- Content type: Original Article
- Published: 09 June 2023
- Pages: 3251 - 3264
-
Unsupervised [18F]Flortaucipir cutoffs for tau positivity and staging in Alzheimer’s disease
Authors (first, second and last of 10)
- Giulia Quattrini
- Clarissa Ferrari
- for the Alzheimer’s Disease Neuroimaging Initiative
- Content type: Original Article
- Open Access
- Published: 05 June 2023
- Pages: 3265 - 3275
-
In vivo evaluation of a novel 18F-labeled PET radioligand for translocator protein 18 kDa (TSPO) in monkey brain
Authors (first, second and last of 12)
- Xuefeng Yan
- Fabrice G. Siméon
- Paolo Zanotti-Fregonara
- Content type: Original Article
- Open Access
- Published: 30 May 2023
- Pages: 2962 - 2970
-
A pharmacological imaging challenge based on 11C-buprenorphine PET-MRI to explore the response to opioids in humans
Authors (first, second and last of 12)
- Claire Leroy
- Sébastien Goutal
- Nicolas Tournier
- Content type: Image of the Month
- Published: 06 May 2023
- Pages: 3153 - 3154
-
Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease
Authors (first, second and last of 53)
- Charles D. Chen
- Austin McCullough
- for the DIAN-TU Study Team
- Content type: Original Article
- Published: 05 April 2023
- Pages: 2669 - 2682
-
Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study
Authors (first, second and last of 14)
- Denise Visser
- Sander C. J. Verfaillie
- Rik Ossenkoppele
- Content type: Original Article
- Open Access
- Published: 28 March 2023
- Pages: 2409 - 2419
-
First-in-human imaging using [11C]MDTC: a radiotracer targeting the cannabinoid receptor type 2
Authors (first, second and last of 17)
- Yong Du
- Jennifer M. Coughlin
- Martin G. Pomper
- Content type: Original Article
- Published: 06 March 2023
- Pages: 2386 - 2393
-
Sex differences in dementia with Lewy bodies: an imaging study of neurotransmission pathways
Authors (first, second and last of 6)
- Cecilia Boccalini
- Nicolas Nicastro
- Valentina Garibotto
- Content type: Original Article
- Open Access
- Published: 24 February 2023
- Pages: 2036 - 2046
-
[18F]FDG PET in conditions associated with hyperkinetic movement disorders and ataxia: a systematic review
Authors (first, second and last of 7)
- Elze R. Timmers
- Marrit R. Klamer
- Marina A. J. Tijssen
- Content type: Review Article
- Open Access
- Published: 27 January 2023
- Pages: 1954 - 1973
-
Assessment of perfusion deficit with early phases of [18F]PI-2620 tau-PET versus [18F]flutemetamol-amyloid-PET recordings
Authors (first, second and last of 20)
- Friederike Völter
- Leonie Beyer
- Matthias Brendel
- Content type: Original Article
- Open Access
- Published: 27 December 2022
- Pages: 1384 - 1394
-
[18F]RO948 tau positron emission tomography in genetic and sporadic frontotemporal dementia syndromes
Authors (first, second and last of 16)
- Alexander F. Santillo
- Antoine Leuzy
- Oskar Hansson
- Content type: Original Article
- Open Access
- Published: 14 December 2022
- Pages: 1371 - 1383
-
Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson’s Disease (PD) and dementia with Lewy bodies (DLB)
Authors (first, second and last of 15)
- Francesco Lanfranchi
- Dario Arnaldi
- Silvia Morbelli
- Content type: Original Article
- Published: 06 December 2022
- Pages: 1090 - 1102
-
Role of brain 2-[18F]fluoro-2-deoxy-D-glucose-positron-emission tomography as survival predictor in amyotrophic lateral sclerosis
Authors (first, second and last of 14)
- Antonio Canosa
- Alessio Martino
- Marco Pagani
- Content type: Original Article
- Open Access
- Published: 29 October 2022
- Pages: 784 - 791